Irreversible electroporation (IRE) efficacy in pancreatic cancer is limited by post-ablation stromal barriers and immune suppression. To address this, we engineered temporally staggered gas-releasing short fiber–microspheres (NOHSM) that spatiotemporally coordinate NO and H 2 S delivery. NOHSM sensitizes pancreatic cancer to IRE by sequentially dismantling the robust extracellular matrix barrier and reversing post-ablation immunosuppression. Mechanistically, the outer short fibers rapidly release NO in response to the glutathione-rich tumor microenvironment. This NO reacts with IRE-induced reactive oxygen species to form peroxynitrite, which activates matrix metalloproteinases to degrade the rigid stroma. Concurrently, the inner hydrogel microspheres continuously generate H 2 S via enzymatic catalysis by tumor-overexpressed cystathionine β-synthase, which inhibits STAT3 phosphorylation to reverse the IRE-induced surge in pro-tumorigenic Th17 cell differentiation. Furthermore, NOHSM triggers a robust antitumor immune cascade, promoting dendritic cell maturation, M1 macrophage polarization, and enhanced CD8 + T cell cytotoxicity. In murine orthotopic pancreatic tumor models, local administration of NOHSM following IRE demonstrated potent primary tumor suppression and elicited a systemic abscopal effect that inhibited distant liver and lung metastases. This work establishes NOHSM as an intelligent IRE-responsive platform to overcome stromal and immune barriers in pancreatic cancer ablation therapy.
No takes yet. Share an insight, caveat, or question.
Jiang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: